| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/04/1995 | WO1995011667A1 Gelatin capsule fill able to foam |
| 05/04/1995 | WO1995011666A1 Improvements in and relating to carrier particles for use in dry powder inhalers |
| 05/04/1995 | WO1995011665A1 Orally-administered dosage form for animals, preparation method therefor and uses thereof |
| 05/04/1995 | WO1995011664A1 Method for preparing a viral aerosol |
| 05/04/1995 | WO1995011663A1 Proteinaceous materials and formulations for sunburn cell protection |
| 05/04/1995 | WO1995006077A3 Polymeric matrices and their uses in pharmaceutical compositions |
| 05/04/1995 | DE4404990C1 Process for producing a sterile prednisolone gel |
| 05/04/1995 | DE4337492A1 Method for incorporating pharmaceutically active substances into hard and soft contact lenses to produce ophthalmological controlled release systems by means of diffusion-controlled sorption |
| 05/04/1995 | CA2203916A1 Proteinaceous materials and formulations for sunburn cell protection |
| 05/04/1995 | CA2175089A1 Prokaryotic expression of mhc proteins |
| 05/04/1995 | CA2175077A1 Orally-administered dosage form for animals, preparation method therefor and uses thereof |
| 05/04/1995 | CA2175059A1 Granular pharmaceutical preparation |
| 05/04/1995 | CA2174933A1 Detection of h. pylori in the stomach |
| 05/04/1995 | CA2174777A1 Gelatin capsule fill able to foam |
| 05/04/1995 | CA2174767A1 Improvements in and relating to carrier particles for use in dry powder inhalers |
| 05/04/1995 | CA2174747A1 Use of lobeline for the treatment of nicotine withdrawal |
| 05/04/1995 | CA2169453A1 Inhibition of hiv mucosal infection |
| 05/03/1995 | EP0650736A1 Method for sterilizing recombinant human serum albumin pharmaceutical preparation |
| 05/03/1995 | EP0650730A1 Rapamycin formulations for oral administration |
| 05/03/1995 | EP0650729A1 Rapamycin formulations for IV injection |
| 05/03/1995 | EP0650722A2 Invasive particles with protein coating |
| 05/03/1995 | EP0650721A1 Cyclosporin soft capsule |
| 05/03/1995 | EP0650377A1 Implanting devices for release of neuroinhibitory compounds |
| 05/03/1995 | EP0650373A1 Sustained release alginate fibre and process for the preparation thereof. |
| 05/03/1995 | EP0650370A1 Methods and compositions for targeting specific tissue |
| 05/03/1995 | EP0650366A1 Compositions and methods for treating wounds |
| 05/03/1995 | EP0650359A1 TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING THE ACTIVE SUBSTANCE 17-$g(b)-OESTRADIOL (ANHYDROUS) |
| 05/03/1995 | EP0650354A1 Solid and liquid solutions of drugs which are not readily soluble in water |
| 05/03/1995 | EP0650353A1 Palatable pharmaceutical compositions |
| 05/03/1995 | EP0650348A1 Glucomannan spongeous matrices |
| 05/03/1995 | EP0641196A4 Microencapsulation of cells. |
| 05/03/1995 | EP0586488B1 Pharmaceutical enema preparation |
| 05/03/1995 | EP0569541B1 Growth factor containing matrix for the treatment of cartilage lesions |
| 05/03/1995 | EP0500605B1 Cosmetic deodorants |
| 05/03/1995 | EP0470144B1 Beta-hydroxamate d-aspartic acid for treatment of viral infections and tumours |
| 05/03/1995 | EP0456724B1 Composition and method for treating benign prostatic hypertrophy |
| 05/03/1995 | CN1102118A Honggenshensan powder |
| 05/03/1995 | CN1102116A Weibiqing traditional Chinese medicine for curing gastric disease and its prescription and preparing method |
| 05/03/1995 | CN1102110A Fumeidan pill-traditional Chinese Medicine Capable of Resisting senility and improving one's looks |
| 05/03/1995 | CN1102109A Jiangtangbao-traditional Chinese medicine capable of reducing blood sugar |
| 05/03/1995 | CN1102107A Gucixiao capable of removing spur and preparation technology thereof |
| 05/03/1995 | CN1102106A Quick-acting Weikang medicine for curing gastritis |
| 05/03/1995 | CN1102105A Plaster for curing cough with dyspnea |
| 05/03/1995 | CN1102104A Adhesive plaster capable of detoxicating and resolving a mass |
| 05/03/1995 | CN1102102A Suppository for curing prostatosis |
| 05/03/1995 | CN1102095A Long-acting androgen preparation-undecylic acid testis injection |
| 05/03/1995 | CN1102094A Granular preparation |
| 05/03/1995 | CN1102093A Isoniazid aerosol, spray and preparation method thereof |
| 05/02/1995 | US5412089 Antitumor, antiviral |
| 05/02/1995 | US5412072 Water soluble high molecular weight polymerized drug preparation |
| 05/02/1995 | US5411993 Anti-inflammatory, stable aqueous preparation comprising azulene sodium sulfonate and polyhydric alcohol |
| 05/02/1995 | US5411971 N-alkylenepiperidino compounds, their enantiomers and pharmaceutical compositions |
| 05/02/1995 | US5411952 Ocular cyclosporine composition |
| 05/02/1995 | US5411951 Prolonged release of biologically active somatotropin |
| 05/02/1995 | US5411947 converting drugs having suitable functional groups to 1-O-alkyl-, 1-O-acyl-, 1-S-acyl, and 1-S-alkyl-sn-glycero-3-phosphate derivatives; drugs such as AZT, cladribine, AICA-Riboside |
| 05/02/1995 | US5411945 Containing saccharides |
| 05/02/1995 | US5411746 Solutions with opacifiers of titanium dioxide and iron oxide and immobilizer for dyes |
| 05/02/1995 | US5411745 Powder layer beads for sustained release analgesics |
| 05/02/1995 | US5411744 Silicone vesicles and entrapment |
| 05/02/1995 | US5411743 Prevention of synovial adhesions |
| 05/02/1995 | US5411740 Transdermal administration of oxybutynin |
| 05/02/1995 | US5411739 Transdermal delivery of nicotine |
| 05/02/1995 | US5411738 Maintaining lidocaine intradermally at a concentration sufficient to induce analgesia |
| 05/02/1995 | US5411737 Slow release syneresing polymeric drug delivery device |
| 05/02/1995 | US5411735 Pastille for facilitating the ingestion of medicinal tablets by pets |
| 05/02/1995 | CA1335425C Antiviral or antibacterial compound and method of use |
| 04/27/1995 | WO1995011043A1 Base for sustained-release preparation, sustained-release preparation, and process for producing the preparation |
| 04/27/1995 | WO1995011042A1 Pernasal composition and pernasal preparation containing the same |
| 04/27/1995 | WO1995011039A1 PHARMACEUTICAL COMPOSITION CONTAINING CYCLOSPORINE A AND α-TOCOPHEROL |
| 04/27/1995 | WO1995011032A1 Senna dosage form |
| 04/27/1995 | WO1995011025A1 A composition for preventing and treating kinetotia syndrome |
| 04/27/1995 | WO1995011024A1 Picosulphate dosage form |
| 04/27/1995 | WO1995011023A1 Method for the preparation of quinolone-containing oral compositions |
| 04/27/1995 | WO1995011022A1 Method for the preparation of quinolone-containing oral compositions |
| 04/27/1995 | WO1995011015A1 Composition and method for treating blood vessel disorders of the skin using vitamin k |
| 04/27/1995 | WO1995011011A1 Controlled release osmotic infusion system |
| 04/27/1995 | WO1995011010A1 Methods and compositions for microencapsulation of antigens for use as vaccines |
| 04/27/1995 | WO1995011009A1 Method for preparing microspheres comprising a fluidized bed drying step |
| 04/27/1995 | WO1995011008A2 Methods and compositions for microencapsulation of adjuvants |
| 04/27/1995 | WO1995011007A1 Preparation of medical devices by solid free-form fabrication methods |
| 04/27/1995 | WO1995011006A1 Highly active sulphonyl urea preparations exhibiting rapid or controlled release of the active substance, and method of producing them |
| 04/27/1995 | WO1995010999A1 Novel composition |
| 04/27/1995 | CA2174666A1 Composition and method for treating blood vessel disorders of the skin using vitamin k |
| 04/27/1995 | CA2174538A1 Base for sustained-release preparation, sustained-release preparation, and process for producing the preparation |
| 04/27/1995 | CA2174444A1 Method for the preparation of quinolone-containing oral compositions |
| 04/27/1995 | CA2174324A1 Pernasal composition and pernasal preparation containing the same |
| 04/27/1995 | CA2173366A1 Highly active sulphonyl urea preparations exhibiting rapid or controlled release of the active substance, and method of producing them |
| 04/27/1995 | CA2134293A1 Pharmaceutical preparation for the parenteral, enteral and dermal administration of virtually insoluble medicinal substances and a process for its production |
| 04/26/1995 | EP0649662A1 Biodegradable implant precursor |
| 04/26/1995 | EP0649660A2 Pharmaceutical composition for parenteral, enteral and dermal administration of essentially insoluble drugs and process for their preparation |
| 04/26/1995 | EP0649659A1 Rapamycin formulation for IV injection |
| 04/26/1995 | EP0649653A1 Use of partially methylated beta-cyclodextrins as absorption enhancers in the manufacture of pharmaceutical compositions for the transdermal administration of active agents |
| 04/26/1995 | EP0649652A1 Minimal-dose beta-blocker preparations |
| 04/26/1995 | EP0649651A1 Soft gelatin capsule manufacture |
| 04/26/1995 | EP0649650A1 Bioadhesive pharmaceutical composition for controlled release of drugs |
| 04/26/1995 | EP0649649A2 Colloidal, dispersible formulations of active substances |
| 04/26/1995 | EP0649358A1 High speed process for preparing orifices in pharmaceutical dosage forms |
| 04/26/1995 | EP0649302A1 Therapeutic and diagnostic use of modified polymeric microcapsules |
| 04/26/1995 | EP0527887B1 Pharmaceutical composition |
| 04/26/1995 | EP0526481B1 The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations |